1. Home
  2. RCT vs IVVD Comparison

RCT vs IVVD Comparison

Compare RCT & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCT
  • IVVD
  • Stock Information
  • Founded
  • RCT 2014
  • IVVD 2020
  • Country
  • RCT United Kingdom
  • IVVD United States
  • Employees
  • RCT N/A
  • IVVD N/A
  • Industry
  • RCT
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • RCT
  • IVVD Health Care
  • Exchange
  • RCT NYSE
  • IVVD Nasdaq
  • Market Cap
  • RCT 68.1M
  • IVVD 69.0M
  • IPO Year
  • RCT 2025
  • IVVD 2021
  • Fundamental
  • Price
  • RCT $2.00
  • IVVD $0.74
  • Analyst Decision
  • RCT Strong Buy
  • IVVD Strong Buy
  • Analyst Count
  • RCT 2
  • IVVD 3
  • Target Price
  • RCT $5.00
  • IVVD $5.85
  • AVG Volume (30 Days)
  • RCT 5.0M
  • IVVD 1.3M
  • Earning Date
  • RCT 05-17-2025
  • IVVD 08-13-2025
  • Dividend Yield
  • RCT N/A
  • IVVD N/A
  • EPS Growth
  • RCT N/A
  • IVVD N/A
  • EPS
  • RCT N/A
  • IVVD N/A
  • Revenue
  • RCT $46,499,285.00
  • IVVD $36,688,000.00
  • Revenue This Year
  • RCT N/A
  • IVVD $446.60
  • Revenue Next Year
  • RCT N/A
  • IVVD $112.63
  • P/E Ratio
  • RCT N/A
  • IVVD N/A
  • Revenue Growth
  • RCT 134.76
  • IVVD N/A
  • 52 Week Low
  • RCT $1.17
  • IVVD $0.35
  • 52 Week High
  • RCT $5.36
  • IVVD $2.74
  • Technical
  • Relative Strength Index (RSI)
  • RCT N/A
  • IVVD 48.03
  • Support Level
  • RCT N/A
  • IVVD $0.70
  • Resistance Level
  • RCT N/A
  • IVVD $0.77
  • Average True Range (ATR)
  • RCT 0.00
  • IVVD 0.05
  • MACD
  • RCT 0.00
  • IVVD -0.00
  • Stochastic Oscillator
  • RCT 0.00
  • IVVD 45.94

About RCT REDCLOUD HOLDINGS PLC

RedCloud Holdings PLC developed and operates the RedCloud Platform, which facilitates the trading of everyday consumer supplies of fast-moving consumer goods (FMCG) products across business supply chains. The Platform solves old problem of how to unlock and enable access of key purchase and sales data between brands, distributors and retailers in growth consumer markets. Its Platform has AI and machine learning capabilities that provide brands, distributors and retailers with trading and product insights and data to help make commercial decisions regarding their business operations. Geographically, Key revenue is generated from Nigeria.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: